Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features.
Mihir D WechalekarLin-Pierre ZhaoMonika M KutynaLih En HongJoule LiKevin HungHamish S ScottAnna L BrownChristopher N HahnKarin KassahnDariusz LadonDavid T YeungDaniel ThomasMirinal S PatnaikSusanna ProudmanLionel AdesMithun Vinod ShahChung Hoow KokDevendra K HiwasePublished in: Blood cancer journal (2024)